Publication: Pharmacokinetics of mefloquine in treatment failure
Issued Date
1991-12-01
Resource Type
ISSN
00383619
Other identifier(s)
2-s2.0-0026399086
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Southeast Asian Journal of Tropical Medicine and Public Health. Vol.22, No.4 (1991), 523-526
Suggested Citation
J. Karbwang, K. N. Bangchang, A. Thanavibul, D. Bunnag, T. Harinasuta Pharmacokinetics of mefloquine in treatment failure. Southeast Asian Journal of Tropical Medicine and Public Health. Vol.22, No.4 (1991), 523-526. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/22094
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Pharmacokinetics of mefloquine in treatment failure
Other Contributor(s)
Abstract
The pharmacokinetics of mefloquine at the therapeutic dose of 750 mg single orally were compared between cured and recrudescent patients with acute uncomplicated falciparum malaria. Mefloquine was well-tolerated during the study. The side-effects found were nausea, vomiting and diarrhea. Five patients showed R-I and two showed R-II types of response. All recrudescent patients came from the eastern border of Thailand. The time taken to clear the parasites (PCT) was significantly longer in patients with recrudescence (99.6 ± 36.9 and 63.0 ± 8.9 hours); however, there was no difference regarding fever clearance time (FCT : 39.0 ± 16.1 and 31.0 ± 21.3 hours). The maximum concentration (Cmax) and the concentration on the first and second days in cured patients were significantly higher than those of treatment failure patients. Other pharmacokinetic parameters appeared to be similar in both groups. The present study indicates the existence of mefloquine-resistant falciparum malaria in the eastern border of Thailand. Inadequate mefloquine concentration may play an important role in this aspect. In addition, this study also suggests that Cmax or the concentrations on the first or second day of treatment may be used as guidelines to predict the outcome of treatment.